CIPLA LTD vs VIJAYA DIAGNOSTIC CEN LTD

A side-by-side comparison of CIPLA LTD (CIPLA) and VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, CIPLA LTD leads CIPLA vs VIJAYA on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

29.54
P/E ratio
79.79
3.42
P/B ratio
14.85
0.90%
Dividend yield
0.15%
₹48.02
EPS
₹16.81

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

11.60%
Return on equity
19.70%
15.00%
Return on capital
21.00%
21.00%
EBITDA margin
41.00%
13.71%
Net margin
21.25%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

7.37%
Revenue CAGR (3Y)
21.04%
10.88%
Profit CAGR (3Y)
26.73%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.15L Cr
Market cap
₹13,777 Cr
₹28,163 Cr
Revenue
₹814 Cr
₹3,862 Cr
Net profit
₹173 Cr
0.02
Debt / equity
0.44
CIPLA LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
  • ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.34%"]
VIJAYA DIAGNOSTIC CEN LTD
  • ["Stock is trading at 14.9 times its book value", "Working capital days have increased from -3.87 days to 65.1 days"]
CIPLA LTD full analysis VIJAYA DIAGNOSTIC CEN LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

CIPLA LTD vs VIJAYA DIAGNOSTIC CEN LTD: Share Price, Valuation & Which to Buy | DocStoX